IceCure Medical Ltd — Balance Sheet (NASDAQ:ICCM) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Total assets 32.28 M30.19 M16.41 M12.58 M12.58 M Total liabilities 5.32 M4.77 M4.25 M5.67 M5.67 M Total equity 26.96 M25.42 M12.16 M6.9 M6.9 M Total liabilities & shareholders' equities 32.28 M30.19 M16.41 M12.58 M— Total debt ————— Net debt —————

Haberler

IceCure Medical, Ocak 2026’da özel hissedar toplantısı düzenleyecek

IceCure Medical schedules special shareholder meeting for January 2026

Nvidia, Target, TJX, and more set to report earnings Wednesday

Viatris (VTRS) Beats Q3 Earnings and Revenue Estimates

Acadia Healthcare (ACHC) Beats Q3 Earnings and Revenue Estimates

IceCure Medical hisseleri, kriyoablasyon çalışmasının sağkalım oranlarını artırdığını göstermesiyle yükseldi

IceCure Medical stock jumps after cryoablation study shows improved survival rates

Freezing Cancer With IceCure: ProSense Cryoablation System Receives FDA Marketing Authorization For Early-Stage Breast Cancer Treatment - Icecure Medical (NASDAQ:ICCM)

H.C. Wainwright, IceCure Medical için hedef fiyatı 2,00 dolardan 2,50 dolara yükseltti

IceCure Medical stock price target raised to $2.50 from $2.00 at H.C. Wainwright

IceCure Medical Ltd (ICCM) U.S. FD&A's MarketingAuthorizationforProSenseCryoablation Call

ICCM Shares Rise as FDA Clears ProSense for Breast Cancer Treatment